ModeRNA, Stealth Startup Backed By Flagship VentureLabs, Unveils New Way to Make Stem Cells  
10/5/2010 7:53:33 AM

Xconomy -- ModeRNA Therapeutics, a new startup out of Cambridge, MA-based Flagship VentureLabs, announced it has developed a method for producing human induced pluripotent stem cells, which are embryonic-like stem cells that are formed by reprogramming adult stem cells. Flagship and three other scientists co-founded the startup this summer with an undisclosed amount of Series A funding, as first reported by Dow Jones VentureWire this morning.